Posted on 12/5/18
Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital
RALEIGH, N.C., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and . . .
Posted on 12/2/18
Transenterix Using Robotics to Usher in a New Age of Surgery
As technology continues to alter the global market, a Research Triangle Park-based medical devices company believes it will pioneer a shift in the future of health . . .
Posted on 11/29/18
UNC REX Announced Its Plan To Build New Cancer Center
UNC REX Healthcare announced Wednesday its plan to open a new Cancer Center to meet the growing need for oncology treatment and services.Construction on the four-story, . . .
Posted on 11/28/18
Liquidia Technologies Provides Leadership Update
RESEARCH TRIANGLE PARK, N.C., Nov. 27, 2018 (GLOBE NEWSWIRE) -- LQDA) Liquidia Technologies, Inc. (Nasdaq:LQDA) a late-stage clinical biopharmaceutical company focused on the development and commercialization . . .
Posted on 11/20/18
Cambrex To Acquire Avista Pharma Solutions For $252M
Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms
Posted on 11/18/18
Justice Department and Atrium Health Reach Settlement
Atrium Health and the U.S. Department of Justice have reached an agreement to bring an end to the government’s litigation about health care costs.There was no . . .
Posted on 11/18/18
Fennec Pharmaceuticals Reports Higher Third Quarter Loss Than In 2017
Fennec Pharmaceuticals, a Durham-based pharmaceutical company, reported a net loss of $2.7 million or 14 cents a share for the third quarter of 2018, slightly larger . . .
Posted on 11/15/18
Heat Biologics Reports Lower-than-expected Earnings
Biopharmaceutical company Heat Biologics Inc. reported lower-than-expected earnings Thursday due to higher research and development expenses, according to a filing with the Securities and Exchange Commission.The . . .
Posted on 11/15/18
Innovate Bio Reports Better-than-expected Third Quarter Earnings
Innovate Biopharmaceuticals Inc., a Raleigh-based drug development company, reported a third quarter loss on Wednesday that beat analyst estimates.The company reported a net loss of $800,000, . . .
Posted on 11/7/18
G1 Therapeutics Reports Q3 2018 Financial Results and Corporate Update
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today reported financial results and provided an . . .
Posted on 11/6/18
Syneos Health Reports Strong Earnings Following Recent Merger
Syneos Health Inc. reported higher-than-expected earnings Tuesday after recognizing its merger with inVentiv Health and acquisition of Kinapse, according to a filing with the Securities and . . .
Posted on 11/6/18
Syneos Health Reports Third Quarter 2018 Results
RALEIGH, N.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a CRO and a CCO, today reported financial results . . .
Posted on 11/5/18
PRA Health Sciences Reports 29.3 Percent Increase in Earnings
PRA Health Sciences Inc. reported a 29.3 percent increase in earnings for the third quarter of 2018, according to a company filing made Wednesday. Adjusted net . . .
Posted on 10/30/18
Glenmark Pharmaceuticals Celebrates the Inauguration of its U.S. Manufacturing Site in Monroe, North Carolina
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced the official inauguration of its manufacturing site in Monroe, North Carolina. The Monroe facility will serve as the . . .
Posted on 10/17/18
Innovate Bio’s CEO Saw a 59 Percent Decrease in 2017 Compensation
Innovate Biopharmapueticals Inc.’s chief executive officer saw a 59 percent decrease in total compensation in the company’s 2017 fiscal year due to a decrease in option . . .
Posted on 10/9/18
UNC-Chapel Hill Researchers File Patent For Dengue Virus Vaccine
Three researchers at UNC-Chapel Hill’s School of Medicine filed an application with the U.S. Patent and Trademark Office for a new dengue virus vaccine.The filing was . . .
Posted on 10/8/18
G1 Therapeutics Chair Sells 10,000 Shares, Profits $493,000
The chair of G1 Therapeutics Inc., a Durham-based biopharmaceutical company, sold 10,000 of the company’s shares for a net gain of $493,310, according to a filing . . .
Posted on 9/23/18
G1 Therapeutics Closes Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced the closing of an underwritten . . .
Posted on 9/20/18
G1 Therapeutics Sells Shares Worth $180M to Fund Drug Development
Clinical oncology company G1 Therapeutics Inc. is raising $180 million to advance its drug development programs by selling 3 million shares of common stock in a . . .
Posted on 9/19/18
G1 Therapeutics Announces Pricing of Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., Sept. 18, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced the pricing of an underwritten . . .
Posted on 9/18/18
G1 Therapeutics Announces Proposed Offering of Common Stock
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that it has commenced an . . .
Posted on 9/17/18
BioCryst Awarded Additional $3.5M in Federal Funding for Yellow Fever Treatment Tests
BioCryst Pharmaceuticals Inc. has been given an additional $3.5 million by the federal government to support clinical trials using one of the company’s signature drugs in . . .
Posted on 9/17/18
Aramark To Sell Its Healthcare Technologies Business For $300M To TRIMEDX
Aramark (NYSE: ARMK) announced today that it has signed a definitive agreement to sell its Healthcare Technologies (HCT) business for $300 million to TRIMEDX.
Posted on 9/11/18
Here's Why BioCryst Pharmaceuticals Rose 21.3% in August
What happenedShares of BioCryst Pharmaceuticals (NASDAQ:BCRX) rose over 21% last month, according to data provided by S&P Global Market Intelligence. In the beginning of the month, . . .
Posted on 9/6/18
Start-up Scinovia Prepares to Enter Heart Device Market
Jim Sund is getting a flash from the past.During his childhood, he only read one book outside of class. Its subject: the heart. To Sund, this . . .
Charlotte Raleigh
